Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOX
Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOX
Not yet recruiting · NCT06210360 · Registry updated 2024-01-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOX | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Not yet recruiting | Phase 2 | 2024-01-18 | NCT06210360 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Changhai Hospital | 141 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||